Ancillary Studies to Large Ongoing Clinical Projects (R21) | Apply Online

Opportunity Summary:

The grant opportunity "Ancillary Studies to Large Ongoing Clinical Projects (R21)" (Funding Opportunity Number RFA-AR-13-011) is a National Institutes of Health (NIH) announcement tied to the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It is designed to support short, time-sensitive ancillary studies that can be added onto large clinical efforts that are already underway. Instead of funding a brand-new major clinical trial or cohort from scratch, this program focuses on taking advantage of established, well-characterized patient populations, existing study infrastructure, accumulated data, and available biological samples that are already being collected through an ongoing "parent" project.

The central idea is efficiency and scientific return. The parent project can be a large clinical trial, a large observational study, or even a disease registry, as long as it provides access to a sufficiently sized cohort with strong clinical characterization and the operational capacity to incorporate an extra set of research questions or measurements. NIAMS is essentially inviting researchers to piggyback high-value questions onto ongoing studies where the marginal cost and time are lower than starting over, while still producing meaningful new insights relevant to arthritis, musculoskeletal diseases, and skin conditions within the NIAMS portfolio.

A defining feature of this FOA is that it is built for situations where timing matters. Applications must clearly explain why the proposed ancillary work is time sensitive and why it requires an expedited review and award process. For example, the opportunity is meant for add-on studies that need to collect extra samples or measurements during a specific window of the parent study, or where a rapidly closing enrollment period or follow-up schedule would make the ancillary work impossible if funding is delayed. Because of that urgency, NIAMS offers an accelerated review and award pathway compared with typical NIH timelines.

To be considered responsive, an application must show that the parent study has enough time left to carry out the ancillary research. The FOA requires a timeline that demonstrates feasibility within the remaining life of the parent project, rather than vague assurances. It also requires documentation that the ancillary study has permission to use the parent project resources, including access to the cohort, relevant datasets, and any biological materials. In practical terms, this means applicants need clear coordination with the parent study leadership and must be able to show that the parent project agrees to the ancillary study and can integrate it without undermining the main study aims.

From a funding and administrative standpoint, this is an NIH discretionary grant using the R21 activity mechanism, which typically supports exploratory, developmental projects rather than large-scale multi-year trials. The award ceiling listed is $200,000, with an estimated total program funding level of $1.5 million and an expectation of about 6 awards. There is no cost sharing or matching requirement. The program is categorized under Health, and it is associated with CFDA number 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research).

Eligibility is broad and includes many types of U.S. and non-U.S. entities. Eligible applicants include public and private institutions of higher education, nonprofit organizations (both with and without 501(c)(3) status), for-profit organizations (including small businesses), and a wide range of government entities such as state, county, city/township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. Tribal governments (federally recognized and other than federally recognized) and tribal organizations are eligible, as are tribally controlled colleges and universities. The FOA also explicitly includes various institution types such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations. Importantly, foreign institutions may apply, foreign components are allowed, and non-U.S. components of U.S. organizations are also eligible, consistent with NIH policy.

In terms of timing, the opportunity was posted July 20, 2012, with an original and current closing date of April 16, 2013, and an archive date of May 17, 2013. That means this specific announcement is historical rather than currently open, but the structure is still a useful model for understanding how NIAMS has supported add-on clinical research in a fast-moving setting.

Overall, the FOA is meant to squeeze more scientific value out of major clinical investments that already exist by funding focused, add-on studies that deepen understanding of NIAMS-relevant diseases or organ systems. The expected outcome is that these ancillary projects will increase the scientific yield of the parent studies and help identify new leads for diagnosis, treatment, and prevention, especially where collecting the needed data or specimens is only possible while the parent project is still active.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: CESU Study of the Geology of NLCS Unit Prehistoric Trackways National Monument , Southern New Mexico

Previous opportunity: Ancillary Studies to Large Ongoing Clinical Projects (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AR 13 011

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AR 13 011) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AR 13 011", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.